TRPC5
Basic information
Region (hg38): X:111768011-112082776
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TRPC5 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 32 | 37 | ||||
missense | 22 | 26 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 2 | 2 | ||||
non coding | 2 | |||||
Total | 0 | 0 | 23 | 38 | 4 |
Variants in TRPC5
This is a list of pathogenic ClinVar variants found in the TRPC5 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
X-111776381-C-T | TRPC5-related disorder | Uncertain significance (Jan 02, 2024) | ||
X-111776395-A-G | not specified | Uncertain significance (Aug 17, 2022) | ||
X-111776406-T-G | TRPC5-related disorder | Likely benign (Nov 15, 2021) | ||
X-111776448-T-C | TRPC5-related disorder | Likely benign (Jan 02, 2024) | ||
X-111776450-C-T | not specified • TRPC5-related disorder | Uncertain significance (Mar 27, 2023) | ||
X-111776462-A-G | TRPC5-related disorder | Uncertain significance (Aug 29, 2024) | ||
X-111776465-T-A | TRPC5-related disorder | Uncertain significance (Feb 22, 2024) | ||
X-111776495-G-C | TRPC5-related disorder | Uncertain significance (Aug 01, 2023) | ||
X-111776501-C-T | TRPC5-related disorder | Uncertain significance (Jan 18, 2024) | ||
X-111776536-T-G | not specified | Uncertain significance (Nov 21, 2023) | ||
X-111776561-C-T | TRPC5-related disorder | Likely benign (Mar 30, 2022) | ||
X-111776562-T-C | TRPC5-related disorder | Likely benign (Sep 17, 2021) | ||
X-111776584-G-A | not specified | Uncertain significance (Mar 01, 2023) | ||
X-111776604-C-A | TRPC5-related disorder | Uncertain significance (Apr 25, 2024) | ||
X-111776608-C-T | TRPC5-related disorder | Uncertain significance (Jul 09, 2024) | ||
X-111776616-C-A | not specified | Uncertain significance (Jul 25, 2023) | ||
X-111776645-T-C | TRPC5-related disorder | Uncertain significance (Mar 08, 2024) | ||
X-111776655-A-G | TRPC5-related disorder | Likely benign (Oct 01, 2022) | ||
X-111776671-T-C | TRPC5-related disorder | Uncertain significance (Mar 21, 2024) | ||
X-111776715-A-T | TRPC5-related disorder | Likely benign (Feb 15, 2024) | ||
X-111776732-G-A | not specified • TRPC5-related disorder | Uncertain significance (Apr 06, 2023) | ||
X-111776834-A-G | Uncertain significance (Oct 01, 2016) | |||
X-111776840-AAG-A | TRPC5-related disorder | Uncertain significance (Jan 15, 2024) | ||
X-111776864-G-T | TRPC5-related disorder | Likely benign (Oct 29, 2021) | ||
X-111776868-C-A | TRPC5-related disorder | Likely benign (Sep 10, 2019) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
TRPC5 | protein_coding | protein_coding | ENST00000262839 | 10 | 308462 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
1.00 | 0.000270 | 125411 | 1 | 2 | 125414 | 0.0000120 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.27 | 197 | 375 | 0.525 | 0.0000288 | 6435 |
Missense in Polyphen | 65 | 175.8 | 0.36975 | 2948 | ||
Synonymous | -0.413 | 146 | 140 | 1.04 | 0.0000104 | 1869 |
Loss of Function | 4.72 | 1 | 27.9 | 0.0358 | 0.00000213 | 484 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000761 | 0.0000615 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000132 | 0.00000882 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.0000549 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Thought to form a receptor-activated non-selective calcium permeant cation channel. Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Has also been shown to be calcium-selective (By similarity). May also be activated by intracellular calcium store depletion. {ECO:0000250, ECO:0000269|PubMed:16284075}.;
- Pathway
- Axon guidance - Homo sapiens (human);ion channels and their functional role in vascular endothelium;Stimuli-sensing channels;Ion channel transport;Transport of small molecules;TRP channels
(Consensus)
Recessive Scores
- pRec
- 0.174
Intolerance Scores
- loftool
- 0.0223
- rvis_EVS
- -0.47
- rvis_percentile_EVS
- 23.51
Haploinsufficiency Scores
- pHI
- 0.154
- hipred
- Y
- hipred_score
- 0.792
- ghis
- 0.406
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.0289
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Trpc5
- Phenotype
- behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); homeostasis/metabolism phenotype; cellular phenotype;
Gene ontology
- Biological process
- calcium ion transport;manganese ion transport;positive regulation of cytosolic calcium ion concentration;nervous system development;positive regulation of cell population proliferation;positive regulation of peptidyl-threonine phosphorylation;neuron differentiation;positive regulation of axon extension;negative regulation of dendrite morphogenesis;regulation of cytosolic calcium ion concentration;calcium ion transmembrane transport;regulation of membrane hyperpolarization
- Cellular component
- cytoplasm;plasma membrane;integral component of plasma membrane;dendrite;growth cone;cation channel complex;calcium channel complex;neuronal cell body;membrane raft
- Molecular function
- actin binding;calcium channel activity;protein binding;store-operated calcium channel activity;clathrin binding;actinin binding;ATPase binding;inositol 1,4,5 trisphosphate binding